Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: An ACTTION study

Pain

Volumn 155, Issue 8, 2014, Pages 1622-1631

  Farrar, John T ^a   Troxel, Andrea B ^a   Haynes, Kevin ^a   Gilron, Ian ^b   Kerns, Robert D ^c,d   Katz, Nathaniel P ^e,f   Rappaport, Bob A ^g   Rowbotham, Michael C ^h   Tierney, Ann M ^a   Turk, Dennis C ⁱ   Dworkin, Robert H ^j  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c Pain Research Informatics Multimorbidities and Education Center VA Connecticut Healthcare   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Analgesic Solutions   (United States)

^f TUFTS UNIVERSITY   (United States)

^g CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^h CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j UNIVERSITY OF ROCHESTER   (United States)

more..

Author keywords

Assay sensitivity; Neuropathic pain; Pain measurement; Randomized controlled trials as topic; Reproducibility of results; Research design; Treatment efficacy

Indexed keywords

GABAPENTIN; PLACEBO; PREGABALIN; 4 AMINOBUTYRIC ACID; AMINE; ANALGESIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

AGED; ARTICLE; BASELINE 7 DAY PAIN DIARY; BODY MASS; BODY WEIGHT; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPATHIC PAIN; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; TREATMENT RESPONSE; ADULT; ANALOGS AND DERIVATIVES; DIABETIC NEUROPATHIES; MIDDLE AGED; NEURALGIA; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; DIABETIC NEUROPATHIES; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEURALGIA; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF REPORT; TREATMENT OUTCOME; UNITED STATES;

EID: 84904671682     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2014.05.009     Document Type: Article

References (28)

1. B. Colagiuri Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity Clin Trials 7 2010 246 255
2. R.H. Dworkin, A.E. Corbin, J.P. Young Jr., U. Sharma, L. LaMoreaux, H. Bockbrader, E.A. Garofalo, and R.M. Poole Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial Neurology 60 2003 1274 1283
3. R.H. Dworkin, R. Thakur, T. Griesing, U. Sharma, and J.P. Young Randomized clinical trials of pregabalin for neuropathic pain: methods, results, and implications Prog Neurotherapeut Neuropsychopharmocol 3 2008 167 187
4. R.H. Dworkin, D.C. Turk, S. Peirce-Sandner, L.B. Burke, J.T. Farrar, I. Gilron, M.P. Jensen, N.P. Katz, S.N. Raja, B.A. Rappaport, M.C. Rowbotham, M.M. Backonja, R. Baron, N. Bellamy, Z. Bhagwagar, A. Costello, P. Cowan, W.C. Fang, S. Hertz, G.W. Jay, R. Junor, R.D. Kerns, R. Kerwin, E.A. Kopecky, D. Lissin, R. Malamut, J.D. Markman, M.P. McDermott, C. Munera, L. Porter, C. Rauschkolb, A.S. Rice, C. Sampaio, V. Skljarevski, K. Sommerville, B.R. Stacey, I. Steigerwald, J. Tobias, A.M. Trentacosti, A.D. Wasan, G.A. Wells, J. Williams, J. Witter, and D. Ziegler Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations PAIN® 153 6 2012 1148 1158
5. P. Enck, U. Bingel, M. Schedlowski, and W. Rief The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov 12 2013 191 204
6. P. Enck, S. Klosterhalfen, K. Weimer, B. Horing, and S. Zipfel The placebo response in clinical trials: more questions than answers Philos Trans R Soc Lond B Biol Sci 366 2011 1889 1895
7. J.T. Farrar, J.P. Young Jr., L. LaMorequx, J.L. Werth, and R.M. Poole Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale PAIN® 94 2001 149 158
8. FDA. Draft Guidance for Industry. Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products. FDA Website: Food and Drug Administration, Center for Drug Evaluation and Research, 2012.
9. D.G. Finniss, T.J. Kaptchuk, F. Miller, and F. Benedetti Biological, clinical, and ethical advances of placebo effects Lancet 375 2010 686 695
10. R.P. Greenberg, S. Fisher, and J.A. Riter Placebo washout is not a meaningful part of antidepressant drug trials Percept Mot Skills 81 1995 688 690
11. R.E. Harris, D.A. Williams, S.A. McLean, A. Sen, M. Hufford, R.M. Gendreau, R.H. Gracely, and D.J. Clauw Characterization and consequences of pain variability in individuals with fibromyalgia Arthritis Rheum 52 2005 3670 3674
12. D.W. Hosmer, and S. Lemeshow Applied logistic regression 2000 John Wiley & Sons New York
13. J. Kleijnen, A.J. de Craen, J. van Everdingen, and L. Krol Placebo effect in double-blind clinical trials: a review of interactions with medications Lancet 344 1994 1347 1349
14. S. Lee, J.R. Walker, L. Jakul, and K. Sexton Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation Depress Anxiety 19 2004 10 19
15. H. Lesser, U. Sharma, L. LaMoreaux, and R.M. Poole Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial Neurology 63 2004 2104 2110
16. J.D. Levine, N.C. Gordon, and H.L. Fields The mechanism of placebo analgesia Lancet 2 1978 654 657
17. M.A. Posternak, and M. Zimmerman Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis Br J Psychiatry 190 2007 287 292
18. M.A. Posternak, M. Zimmerman, G.I. Keitner, and I.W. Miller A reevaluation of the exclusion criteria used in antidepressant efficacy trials Am J Psychiatry 159 2002 191 200
19. R.W. Richter, R. Portenoy, U. Sharma, L. Lamoreaux, H. Bockbrader, and L.E. Knapp Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial J Pain 6 2005 253 260
20. W. Rief, U. Bingel, M. Schedlowski, and P. Enck Mechanisms involved in placebo and nocebo responses and implications for drug trials Clin Pharmacol Ther 90 2011 722 726
21. J. Rosenstock, M. Tuchman, L. LaMoreaux, and U. Sharma Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial PAIN® 110 2004 628 638
22. R. Sabatowski, R. Galvez, D.A. Cherry, F. Jacquot, E. Vincent, P. Maisonobe, M. Versavel, and Study G Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial PAIN® 109 2004 26 35
23. R. Freeman, E. Durso-Decruz, and B. Emir Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses Diabetes Care 31 7 2008 1448 1454
24. R. Temple Enrichment of clinical study populations Clin Pharmacol Ther 88 2010 774 778
25. R. van Seventer, H.A. Feister, J.P. Young Jr., M. Stoker, M. Versavel, and L. Rigaudy Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial Curr Med Res Opin 22 2006 375 384
26. T.D. Wager, and M. Roy Separate mechanisms for placebo and opiate analgesia? PAIN® 150 2010 8 9
27. R.A. Wise, S.J. Bartlett, E.D. Brown, M. Castro, R. Cohen, J.T. Holbrook, C.G. Irvin, C.S. Rand, M.M. Sockrider, and E.A. Sugar American Lung Association Asthma Clinical Research C. Randomized trial of the effect of drug presentation on asthma outcomes: The American Lung Association Asthma Clinical Research Centers J Allergy Clin Immunol 124 2009 436 444
28. A. Yildiz, E. Vieta, M. Tohen, and R.J. Baldessarini Factors modifying drug and placebo responses in randomized trials for bipolar mania Int J Neuropsychopharmcol 14 2011 863 875